サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1468199

人工膵臓デバイスシステム市場レポート：デバイスタイプ、治療タイプ、エンドユーザー、地域別、2024年～2032年

Artificial Pancreas Device Systems Market Report by Device Type, Treatment Type, End-User, and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 135 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
人工膵臓デバイスシステム市場レポート：デバイスタイプ、治療タイプ、エンドユーザー、地域別、2024年～2032年
出版日: 2024年04月08日
発行: IMARC
ページ情報: 英文 135 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の人工膵臓デバイスシステム（APDS）市場規模は、2023年に23億3,850万米ドルに達しました。今後、IMARC Groupは、2024年から2032年の間に10.3%の成長率（CAGR）を示し、市場は2032年までに58億20万米ドルに達すると予測しています。

APDSは、インスリンの分泌を調節することで血糖値を管理するクローズドループまたは自動インスリン分泌システムを指します。持続血糖モニター（CGM）、皮下インスリン注入ポンプ、モニターとポンプをつなぐコントローラーで構成されます。リアルタイムのグルコース測定値の評価に基づいて、インスリンの適切なレベルと投与時間を決定する複雑なアルゴリズムを実行します。主に、体内のグルコースレベルが極端に変動するリスクを最小限に抑えるために使用されます。

膵臓がん、膵炎、その他の慢性疾患の有病率の増加は、市場の成長を促進する主な要因の1つです。さらに、加齢関連要因、運動不足、不健康な食事パターンによる糖尿病や肥満の発生が増加していることも、世界中でAPDSが広く採用される要因となっています。効率的な糖尿病モニタリングや低侵襲（MI）ドラッグデリバリーシステムに対する需要の高まりも、市場成長に弾みをつけています。APDSは自動的にグルコースレベルを監視し、制御された量のインスリンを一日中投与します。自動制御と統合されたソフトウェアベースのワイヤレスシステムの開発など、さまざまな技術革新がさらに市場成長に寄与しています。さらに、各国の規制機関や政府は、世界中のヘルスケア・インフラを改善するための研究開発（R&D）に多額の投資を行っています。例えば、米国の食品医薬品協会（US FDA）は、革新的な新製品をどんどん承認しており、これは同国の市場に明るい見通しをもたらしています。

本レポートで扱う主な質問

  • 人工膵臓デバイスシステムの世界市場はこれまでどのように推移し、今後数年間はどのように推移するのか？
  • 主要な地域市場は？
  • COVID-19が世界の人工膵臓デバイスシステム市場に与えた影響は？
  • デバイスタイプ別の市場内訳は？
  • 治療タイプ別の市場内訳は？
  • エンドユーザー別の市場内訳は？
  • 業界のバリューチェーンにおける様々な段階とは？
  • 業界の主な促進要因と課題は何か？
  • 世界の人工膵臓デバイスシステム市場の構造と主要プレイヤーは？
  • 業界の競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 人工膵臓デバイスシステムの世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：デバイスタイプ別

  • スレッショルドサスペンドデバイスシステム
    • 市場動向
    • 市場予測
  • コントロール・ツー・レンジシステム
    • 市場動向
    • 市場予測
  • 制御対ターゲットシステム
    • 市場動向
    • 市場予測

第7章 市場内訳：治療タイプ別

  • バイホルモン
    • 市場動向
    • 市場予測
  • インスリンのみ
    • 市場動向
    • 市場予測
  • ハイブリッド
    • 市場動向
    • 市場予測

第8章 市場内訳：エンドユーザー別

  • 病院
    • 市場動向
    • 市場予測
  • 医療センター
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格指標

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Beta Bionics Inc.
    • Bigfoot Biomedical Inc.
    • Dexcom Inc.
    • Inreda Diabetic B.V.
    • Insulet Corporation
    • Johnson & Johnson
    • Medtronic Inc.
    • F. Hoffmann-La Roche Ltd
    • Tandem Diabetes Care Inc.
図表

List of Figures

  • Figure 1: Global: Artificial Pancreas Device Systems Market: Major Drivers and Challenges
  • Figure 2: Global: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Artificial Pancreas Device Systems Market: Breakup by Device Type (in %), 2023
  • Figure 4: Global: Artificial Pancreas Device Systems Market: Breakup by Treatment Type (in %), 2023
  • Figure 5: Global: Artificial Pancreas Device Systems Market: Breakup by End-User (in %), 2023
  • Figure 6: Global: Artificial Pancreas Device Systems Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 8: Global: Artificial Pancreas Device Systems (Threshold Suspend Device Systems) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 9: Global: Artificial Pancreas Device Systems (Threshold Suspend Device Systems) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Artificial Pancreas Device Systems (Control-to-Range Systems) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Artificial Pancreas Device Systems (Control-to-Range Systems) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Artificial Pancreas Device Systems (Control-to-Target Systems) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Artificial Pancreas Device Systems (Control-to-Target Systems) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Artificial Pancreas Device Systems (Bi-hormonal) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Artificial Pancreas Device Systems (Bi-hormonal) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Artificial Pancreas Device Systems (Insulin Only) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Artificial Pancreas Device Systems (Insulin Only) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Artificial Pancreas Device Systems (Hybrid) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Artificial Pancreas Device Systems (Hybrid) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Artificial Pancreas Device Systems (Hospitals) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Artificial Pancreas Device Systems (Hospitals) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Artificial Pancreas Device Systems (Medical Centres) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Artificial Pancreas Device Systems (Medical Centres) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Artificial Pancreas Device Systems (Other End-Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Artificial Pancreas Device Systems (Other End-Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: North America: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: North America: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: United States: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: United States: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Canada: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Canada: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Asia Pacific: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Asia Pacific: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: China: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: China: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Japan: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Japan: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: India: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: India: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: South Korea: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: South Korea: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Australia: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Australia: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Indonesia: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Indonesia: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: Others: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: Others: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Europe: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Europe: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Germany: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Germany: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: France: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: France: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: United Kingdom: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: United Kingdom: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Italy: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Italy: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Spain: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Spain: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Russia: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Russia: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Others: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Others: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Latin America: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Latin America: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Brazil: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Brazil: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Mexico: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Mexico: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Others: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Others: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Middle East and Africa: Artificial Pancreas Device Systems Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Middle East and Africa: Artificial Pancreas Device Systems Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Global: Artificial Pancreas Device Systems Industry: SWOT Analysis
  • Figure 75: Global: Artificial Pancreas Device Systems Industry: Value Chain Analysis
  • Figure 76: Global: Artificial Pancreas Device Systems Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Artificial Pancreas Device Systems Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Artificial Pancreas Device Systems Market Forecast: Breakup by Device Type (in Million US$), 2024-2032
  • Table 3: Global: Artificial Pancreas Device Systems Market Forecast: Breakup by Treatment Type (in Million US$), 2024-2032
  • Table 4: Global: Artificial Pancreas Device Systems Market Forecast: Breakup by End-User (in Million US$), 2024-2032
  • Table 5: Global: Artificial Pancreas Device Systems Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 6: Global: Artificial Pancreas Device Systems Market: Competitive Structure
  • Table 7: Global: Artificial Pancreas Device Systems Market: Key Players
目次
Product Code: SR112024A1918

The global artificial pancreas device systems (APDS) market size reached US$ 2,338.5 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 5,800.2 Million by 2032, exhibiting a growth rate (CAGR) of 10.3% during 2024-2032.

APDS refers to a closed-loop or automated insulin delivery system that manages blood glucose levels by regulating the production of insulin. It consists of a continuous glucose monitor (CGM), a subcutaneous insulin infusion pump and a controller that links the monitor with the pump. It runs a complex algorithm that determines the adequate levels of insulin and time of delivery based on the evaluation of real-time glucose readings. It is primarily used to minimize the risks of extreme fluctuations of glucose levels in the body.

The increasing prevalence of pancreatic cancer, pancreatitis and other chronic ailments is one of the key factors driving the growth of the market. Furthermore, the growing occurrence of diabetes and obesity, due to age-related factors, physical inactivity and unhealthy dietary patterns, is also contributing to the widespread adoption of APDS across the globe. The rising demand for efficient diabetes monitoring and minimally invasive (MI) drug delivery systems is also providing a boost to the market growth. APDS automatically monitors the glucose levels and administers doses of insulin throughout the day in controlled amounts. Various technological innovations, including the development of software-based wireless systems that are integrated with automated controls, are further contributing to the market growth. Moreover, regulatory bodies and governments of various nations are significantly investing in research and development (R&D) for the improvement of healthcare infrastructure across the globe. For instance, the Food and Drug Association (US FDA) in the United States is approving an increasing number of new and innovative products, which is creating a positive outlook for the market in the country.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global artificial pancreas device systems (APDS) market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on device type, treatment type and end-user.

Breakup by Device Type:

Threshold Suspend Device Systems

Control-to-Range Systems

Control-to-Target Systems

Breakup by Treatment Type:

Bi-hormonal

Insulin Only

Hybrid

Breakup by End-User:

Hospitals

Medical Centres

Others

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined with some of the key players being Beta Bionics Inc., Bigfoot Biomedical Inc., Dexcom Inc., Inreda Diabetic B.V., Insulet Corporation, Johnson & Johnson, Medtronic Inc., F. Hoffmann-La Roche Ltd, Tandem Diabetes Care Inc., etc.

Key Questions Answered in This Report:

  • How has the global artificial pancreas device systems market performed so far and how will it perform in the coming years?
  • What are the key regional markets?
  • What has been the impact of COVID-19 on the global artificial pancreas device systems market?
  • What is the breakup of the market based on the device type?
  • What is the breakup of the market based on the treatment type?
  • What is the breakup of the market based on the end-user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global artificial pancreas device systems market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Artificial Pancreas Device Systems Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Device Type

  • 6.1 Threshold Suspend Device Systems
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Control-to-Range Systems
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Control-to-Target Systems
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Treatment Type

  • 7.1 Bi-hormonal
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Insulin Only
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Hybrid
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by End-User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Medical Centres
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Indicators

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Beta Bionics Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Bigfoot Biomedical Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Dexcom Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Inreda Diabetic B.V.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 Insulet Corporation
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Johnson & Johnson
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Medtronic Inc.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 F. Hoffmann-La Roche Ltd
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
    • 14.3.9 Tandem Diabetes Care Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials